Adverse Drug Reactions in Nigeria’s Geriatric Population and its Prevalence, Etiologies, Implications: A Systematic Review
DOI:
https://doi.org/10.54536/ajcp.v3i1.3197Keywords:
Adverse Drug Reactions, ADRs, Nigeria, Geriatric, Population, Prevalence, Etiologies, Implications, Systematic ReviewAbstract
Adverse drug reactions (ADRs) are a significant public health concern. Although the prevalence of ADRs in the general adult population in Nigeria has been studied and documented, there is limited research on ADRs among the geriatric population. This study conducted a systematic review of existing research to determine the prevalence, etiologies and implications of ADRs among Nigerian geriatric population. A comprehensive search was undertaken using PubMed, ResearchGate, and Google Scholar databases. The Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guideline was used for reporting this systematic review. Six studies met the eligibility criteria for inclusion in this review. The prevalence of ADRs among the geriatrics ranged from 4.4% to 31.1%. The gastrointestinal system was the most commonly affected system, with non-steroidal anti-inflammatory drugs (NSAIDs) being the most frequently implicated class of drugs contributing to ADRs. The prevalence of ADRs in the Nigerian geriatric population is underreported. There are insufficient policies and healthcare personnel specialized in caring for geriatric patients. Strategies should be implemented to reduce the incidence of ADRs among geriatric patients.
Downloads
References
Adedapo, A. D., Adedeji, W. A., Adedapo, I. A., & Adedapo, K. S. (2021). Cohort study on adverse drug reactions in adults admitted to the medical wards of a tertiary hospital in Nigeria: Prevalence, incidence, risk factors and fatality. British Journal of Clinical Pharmacology, 87(4), 1878-1889. https://doi.org/10.1111/bcp.14577.
Aderemi-Williams, R., Awodele, O., & Boyle, C. (2015). Adverse drug reactions amongst adult patients admitted in Lagos State University Teaching Hospital Lagos, Nigeria. Current Drug Safety, 10(2), 136-144. https://doi.org/10.2174/1574886309666140601211211.
Adisa, R., & Omitogun, T. I. (2019). Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, Southwestern Nigeria. BMC Health Services Research, 19, 1-14. https://doi.org/10.1186/s12913-019-4775-9.
Akhideno, P. E., Fasipe, O. J., & Isah, A. O. (2018). The incidence and prevalence of adverse drug reactions among medical inpatients in a Nigerian University Teaching Hospital. Journal of Current Research in Scientific Medicine, 4(2), 86-93.
Alhawassi, T. M., Krass, I., Bajorek, B. V., & Pont, L. G. (2014). A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clinical Interventions in Aging, 9, 2079-2086. https://doi.org/10.2147/CIA.S71178.
Ama, M. I., Ikwuka, A. O., Udeh, F. C., Ekechi, H. O., & Eteudo, A. N. (2023). Sperm Parameters and Testicular Histology of Male Wistar Rats Treated with Phoenix dactylifera After Consumption of Local Mmahi Salt. American Journal of Bioscience and Bioinformatics, 2(1), 41-51. https://doi.org/10.54536/ajbb.v2i1.2275.
Amadi, E. S., Pepple, E. F., Otike-Odibi, B., & Bell-Gam, H. I. (2021). Adverse drug reactions amongst admitted advanced age Africans. World Journal of Advanced Research and Reviews, 12(3), 427-433. https://doi.org/10.30574/wjarr.2021.12.3.0712.
Aronson, J. K., & Ferner, R. E. (2005). Clarification of terminology in drug safety. Drug Safety, 28, 851-870.
Baysah, P. V., Ikwuka, A. O., Udeh, F. C., Bleh, D. P., & Viloria, T. (2023). Pathophysiological effects of alcohol and tobacco consumption on semen parameters of men attending a fertility clinic in West Africa. American Journal of Biomedical and Life Sciences, 11(4), 73-81. https://doi.org/10.11648/j.ajbls.20231104.13.
Borodo, S. B., Jatau, A. I., Mohammed, M., Aminu, N., Shitu, Z., & Sha’aban, A. (2022). The burden of polypharmacy and potentially inappropriate medication in Nigeria: a clarion call for deprescribing practice. Bulletin of the National Research Centre, 46(1), 1-8. https://doi.org/10.1186/s42269-022-00864-3.
Brvar, M., Fokter, N., Bunc, M., & Mozina, M. (2009). The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty. BMC Clinical Pharmacology, 9, 1-8.
Charlesworth, C. J., Smit, E., Lee, D. S., Alramadhan, F., & Odden, M. C. (2015). Polypharmacy among adults aged 65 years and older in the United States: 1988–2010. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences, 70(8), 989-995. https://doi.org/ 10.1093/gerona/glv013.
Cohen, J. (1968). Weighted kappa: nominal scale agreement provision for scaled disagreement or partial credit. Psychological Bulletin, 70(4), 213. https://doi.org/10.1037/h0026256.
Coleman, J. J., & Pontefract, S. K. (2016). Adverse drug reactions. Clinical Medicine, 16(5), 481. https://doi.org/10.7861/clinmedicine.16-5-481.
Davies, E. A., & O’mahony, M. S. (2015). Adverse drug reactions in special populations–the elderly. British Journal of Clinical Pharmacology, 80(4), 796-807. https://doi.org/10.1111/bcp.12596.
Davies, L. E., Spiers, G., Kingston, A., Todd, A., Adamson, J., & Hanratty, B. (2020). Adverse outcomes of polypharmacy in older people: systematic review of reviews. Journal of the American Medical Directors Association, 21(2), 181-187.
de Figueiredo, T. P., de Souza Groia, R. C., Barroso, S. C. C., do Nascimento, M. M. G., & Reis, A. M. M. (2017). Factors associated with adverse drug reactions in older inpatients in teaching hospital. International Journal of Clinical Pharmacy, 39, 679-685.
Drini M. (2017). Peptic ulcer disease and non-steroidal anti-inflammatory drugs. Aust Prescr, 40(3), 91-93. https://doi.org/10.18773/austprescr.2017.037.
Ekechi, H. O., Ikwuka, A. O., Udeh, F. C., & Abraham, J. C. (2023a). Effects of Ethanol Extract of Rauwolfia vomitoria Leaf on Lipid Profile and Cerebellar Histology in Cisplatin-induced Oxidative Stress. British Journal of Medical and Health Research, 10(5), 16-39. https://doi.org/10.5281/zenodo.8042521.
Ekechi, H. O., Ikwuka, A. O., Udeh, F. C., Epete, M. A., & Uche, V. U. (2023)b. Hepatorenal Protective Functions of Coconut Water in Alloxan-Induced Type 1 Diabetes Mellitus. World Journal of Current Medical and Pharmaceutical Research, 5(4), 114-122. https://doi.org/10.37022/wjcmpr.v5i4.276.
Eze, U. I. H., Oparah, C. A., & Lawal, F. A. (2011). Identification of Drug Therapy Problems among Elderly in-patients of a Nigerian Teaching Hospital. Nigerian Journal of Pharmaceutical Research, 9(1), 49-56.
Fasipe, O. J., Akhideno, P. E., & Owhin, O. S. (2019). The observed effect of adverse drug reactions on the length of hospital stay among medical inpatients in a Nigerian University Teaching Hospital. Toxicology Research and Application, 3, 2397847319850451. https://doi.org/10.1177/2397847319850451.
Hadia, R., Joshi, D., Bhil, D., & Maheshwari, R. (2022). Incidence of adverse drug reactions among elderly patients: A systematic review and meta-analysis. Journal of the Scientific Society, 49(2), 91-102.
Ikwuka, A. O. (2015). Risk factors for the pathogenesis of diabetes mellitus type 2. Materials of 84th Scientific and Practical Conference of Students and Young Scientists with International Participation “Innovations in medicine”, p. 19. Available online: http://www.ifnmu.edu.ua/images/snt/files/konferenciya/Tezu_2015.pdf
Ikwuka, A. O. (2017a). Dyslipidemia risk severity in patients with diabetes mellitus type 2 and essential hypertension. Journal of the 21st International Medical Congress of Students and Young Scientists, p. 59.
Ikwuka, A. O. (2017b). Effectiveness of dapagliflozin in patients with diabetes mellitus type 2 and essential hypertension. Book of abstracts of the 7th International Students’ Scientific Conference of Young Medical Researchers, p. 102. Available online: http://www.stn.umed.wroc.pl/files/lm/Accepted_papers.16113.pdf
Ikwuka, A. O. (2017c). Influence of dyslipidemia in patients with diabetes mellitus type 2 and essential hypertension. The Pharma Innovation Journal, 6(3), 101-103. Available online: http://www.thepharmajournal.com/archives/?year=2017&vol=6&issue=3&part=B
Ikwuka, A. O., & Haman, I. O. (2017d). Features of kidney damage in patients with diabetes mellitus type 2 and essential hypertension. Journal of 86th Scientific and Practical Conference of Students and Young Scientists with International Participation “Innovations in medicine”, p. 144. Available online: http://www.ifnmu.edu.ua/images/snt/86-konf-tezi%20(1).pdf
Ikwuka, A. O., Virstyuk, N. G., & Luchko, O. R. (2017)e. Features of the functional state of kidneys in patients with diabetes mellitus type 2 and essential arterial hypertension. Materials of scientific-practical conference with international participation “Babenkivski reading”, p. 48.
Ikwuka, A. O. (2018a). Clinical dynamics in patients with diabetes mellitus type 2 and concomitant essential hypertensive disease treated with dapagliflozin. Journal of the 22nd International Medical Congress of Students and Young Scientists, p. 32.
Ikwuka, A. O. (2018b). Clinical effectiveness of SGLT-2 inhibitors in patients with diabetes mellitus type 2 and essential hypertensive disease. Endocrine Practice, 24(1), 74. https://doi.org/10.1016/S1530-891X(20)47129-0.
Ikwuka, A. O. (2018c). Features of kidney damage in patients with arterial hypertension and type 2 diabetes mellitus and optimization of treatment. Specialized Academic Council IFNMU, Available online: http://www.ifnmu.edu.ua/images/zagalna_informacia/spec_vcheni_radi/2017-2019/%D0%9420.601.01/Ikvuka/Avtoreferat.pdf
Ikwuka, A. O., & Paliy, Yu. (2018d). Structural changes of the left ventricular myocardium in patients with essential arterial hypertension and diabetes mellitus type 2. Abstracts of the 87th Scientific Conference of Students and Young Scientists with International Participation “Innovations in medicine”, p. 25-26. Available online: https://www.ifnmu.edu.ua/images/snt/zaproshennia_eng.pdf
Ikwuka, A. O. (2019a). Clinical dynamics of nephropathy in patients with diabetes mellitus type 2 and concomitant essential hypertensive disease. Clinical Medicine, 19(2), s39. https://doi.org/10.7861/clinmedicine.19-2-s39.
Ikwuka, A. O. (2019b). Clinical effectiveness of GLP-1 RAs in patients with metabolic syndrome diseases. Endocrine Practice, 25(1), 104-105. https://doi.org/10.1016/S1530-891X(20)46611-X.
Ikwuka, A. O., & Virstyuk, N. G. (2019c). Pattern of cardiac remodelling of the left ventricle in patients with essential hypertensive disease and concomitant type 2 diabetes mellitus. Clinical Medicine, 19(3), s92. https://doi.org/10.7861/clinmedicine.19-3-s92.
Ikwuka, A. O., & Virstyuk, N. G. (2021). Influence of SGLT2 inhibitor and A2RB (AT1) on fibrogenesis and heart failure in patients with essential hypertensive disease combined with diabetes mellitus type 2. E-Poster No. 143 of the 44th & 45th Annual General and Scientific Meeting of the West African College of Physicians (WACP), 1 - 3 November, 2021. https://doi.org/ 10.13140/RG.2.2.26912.87047.
Ikwuka, A. O., & Virstyuk, N. (2022). Prognostic markers of nephropathy in patients with dual metabolic syndrome diseases (essential hypertensive disease and concomitant type 2 diabetes mellitus). Endocrine Practice, 28(5), S65-S66. https://doi.org/10.1016/j.eprac.2022.03.164.
Ikwuka, A. O. (2023a). Dr. Aloy’s Core Essential Series (DACES) Medical Genetics. 1st Edition. Science and Education Publishing, USA, p. 9-10. ISBN: 978-1-958293-02-7.
Ikwuka, A. O. (2023b). Dr. Aloy’s Core Essential Series (DACES) Immunology. 1st Edition. Science and Education Publishing, USA, p. 48. ISBN: 978-978-795-866-7.
Ikwuka, A. O., & Virstyuk, N. (2023c). Patterns and Influence of Cardio-Metabolic Insufficiency in Patients with Essential Hypertensive Disease and Concomitant Type 2 Diabetes Mellitus. https://doi.org/(5), S32-S33. https://doi.org/10.1016/j.eprac.2023.03.076.
Ikwuka, A. O., Virstyuk, N. G., Luchko, O. R., & Kobitovych, I. (2023d). Heterogeneity Of Renal Pathogenicity On The Background Of Asymptomatic Hyperuricemia In Patients With Dual Metabolic Syndrome Diseases (Essential Hypertensive Disease and Type 2 Diabetes Mellitus). British Journal of Medical and Health Research, 10(2), 1-9. https://doi.org/10.5281/zenodo.7690636.
Ikwuka, A. O. (2023e). Dr. Aloy’s Core Essential Series (DACES) Hematology. 1st Edition. Science and Education Publishing, USA, p. 47-60. ISBN: 978-1-958293-09-6.
Ikwuka, A. O., Omoju, D. I., & Mahanera, O. K. (2023)f. Profiling of Clinical Dynamics of Type 2 Diabetes Mellitus in Patients: A Perspective Review. World Journal of Current Medical and Pharmaceutical Research, 5(5), 210-218. https://doi.org/10.37022/wjcmpr.v5i5.294.
Ikwuka, A. O., Virstyuk, N., Luchko, O., & Kobitovych, I. (2024). Optimization of treatment in MSD patients using a combination of HMG-CoA reductase inhibitor, SGLT-2 inhibitor and A2RB (AT1): Resultant clinical effectiveness. Endocrine Practice, 30(5), S60-S61. https://doi.org/10.1016/j.eprac.2024.03.243.
Inya, A. U., Achara, A. P., Ikwuka, A. O., Udeh, F. C., Chi-kadibia, U., & Onazi, O. (2023a). Clinical Dynamics of Anemia in Pregnancy: A 16-week Cross-sectional Study of Pregnant Women Who Attended Antenatal Clinic of Federal Medical Center, Keffi, Nasarawa State, Nigeria. American Journal of Clinical Medicine Research, 11(1), 1-9. https://doi.org/10.12691/ajcmr-11-1-1.
Inya, A. U., Achara, A. P., Ikwuka, A. O., Udeh, F. C., Chi-kadibia, U., & Onazi, O. (2023b). Patterns, Peculiarities and Associated Risk Factors of Anemia in Pregnancy: A Case Study of Pregnant Women Attending Antenatal Clinic in North-Central Nigeria. European Journal of Preventive Medicine, 11(2), 21-31. https://doi.org/10.11648/j.ejpm.20231102.12.
Jaspinder, K., Sargun, S., & Kawaljit, K. (2014). Impact of age on the prevalence of chronic diseases in geriatric population. International Research Journal of Biological Sciences, 3(9), 79-85.
Jennings, E. L., Murphy, K. D., Gallagher, P., & O’Mahony, D. (2020). In-hospital adverse drug reactions in older adults; prevalence, presentation and associated drugs—a systematic review and meta-analysis. Age and Ageing, 49(6), 948-958.
Kongkaew, C., Noyce, P. R., & Ashcroft, D. M. (2008). Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Annals of Pharmacotherapy, 42(7-8), 1017-1025.
Mekonnen, A. B., Alhawassi, T. M., McLachlan, A. J., & Brien, J. A. E. (2018). Adverse drug events and medication errors in African hospitals: a systematic review. Drugs - Real World Outcomes, 5, 1-24. https://doi.org/ 10.1007/s40801-017-0125-6
Miediegha, O., & Bunu, S. J. (2020). Pharmacovigilance framework and extent of medications adverse reaction surveillance in Southern Nigeria. World Journal of Pharmaceutical Research, 9(6), 2009-2017. https://doi.org/10.20959/wjpr20206-17727.
Musa, S., Ikwuka, A. O., Udeh, F. C., Musa, A. A., & Chukwuezie, U. C. (2023). CRISPR-Cas9 Genomic Editing as an Innovation in the Management of Sickle Cell Disease: A Systematic Review. American Journal of Medical Science and Innovation, 2(2), 36-48. https://doi.org/10.54536/ajmsi.v2i2.1760.
National Pharmacovigilance Center (NPC), Nigeria. (2014). Guide for Reporting Adverse Reactions to Marketed Drugs. Available online: http://www.rrfa.co.za/wp-content/uploads/2014/01/PV-Guideline-received-2012.pdf
Nwani, P. O., & Isah, A. O. (2017). Frequency and patterns of adverse drug reactions among elderly in-patients in a Nigerian teaching hospital. J Basic Clin Pharm, 8, 245-250.
Ogar, C. K., Abiola, A., Yuah, D., Ibrahim, A., Oreagba, I. A., Amadi, E. C.. & Oshikoya, K. A. (2019). A retrospective review of serious adverse drug reaction reports in the Nigerian VigiFlow database from September 2004 to December 2016. Pharmaceutical Medicine, 33, 145-157. https://doi.org/10.1007/s40290-019-00267-2.
Okezie, E. O., & Olufunmilayo, F. (2008). Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmacoepidemiology and Drug Safety, 17(5), 517-522. https://doi.org/10.1002/pds.1597.
Oli, A. N., Onyeaso, N., Emencheta, S. C., Ofomata, C. M., Kretchy, J. P., Okhamafe, A., & Ele, G. N. (2021). Evaluating antimicrobial prescribing in a Tertiary Healthcare Institution in Nigeria. Journal of Pharmaceutical Policy and Practice, 14(1), 1-6.
Oreagba, I. A., Bada, S. O., & Chuka-Ebene, V. (2015). An intensive study of adverse events in the Medical Unit of a Nigerian Teaching Hospital. Value in Health, 18(3), A86-A87. https://doi.org/10.1016/j.jval.2015.03.506
Oriavwote, P. E., & Ikwuka, A. O. (2022). Patterns and factors influencing self-medication among students of the American International University West Africa (AIUWA), The Gambia. European Journal of Clinical Medicine, 3(2), 33-37. https://doi.org/10.24018/clinicmed.2022.3.2.181.
Oscanoa, T. J., Lizaraso, F., & Carvajal, A. (2017). Hospital admissions due to adverse drug reactions in the elderly: A meta-analysis. European Journal of Clinical Pharmacology, 73, 759-770.
Prince, M. J., Wu, F., Guo, Y., Robledo, L. M. G., O’Donnell, M., Sullivan, R., & Yusuf, S. (2015). The burden of disease in older people and implications for health policy and practice. The Lancet, 385(9967), 549-562. https://doi.org/10.1016/S0140-6736(14)61347-7.
Ramia, E., Zeenny, R. M., Hallit, S., & Salameh, P. (2021). A population-based study of self-reported adverse drug events among Lebanese outpatients. Scientific Reports, 11(1), 7921.
Saka, S. A., Nlooto, M., & Oosthuizen, F. (2018). American Geriatrics Society-Beers Criteria and adverse drug reactions: a comparative cross-sectional study of Nigerian and South African older inpatients. Clinical Interventions in Aging, 13, 2375-2387. https://doi.org/10.2147/CIA.S176899.
Saka, S. A., Oosthuizen, F., & Nlooto, M. (2017). Interventions towards reducing adverse drug reactions among geriatric population in Africa: a scoping review of the literature from 1990–2016. PULA: Botswana Journal of African Studies, 31(1), 180-194.
Shehab, N., Lovegrove, M. C., Geller, A. I., Rose, K. O., Weidle, N. J., & Budnitz, D. S. (2016). US emergency department visits for outpatient adverse drug events, 2013-2014. JAMA, 316(20), 2115-2125. https://doi.org/ 10.1001/jama.2016.16201.
Uche, V. U., Ikwuka, A. O., Udeh, F. C., Okorocha, A. E., Epete, M. A., Ekechi, H. O., Abraham, J. C., & Igwe, E. C. (2023). Associated Risks and Pathogenic Effects of Consumption of Calcium Carbide-Ripened Banana Before and/or During Pregnancy on Maternal and Neonatal Livers. American Journal of Food Science and Technology, 2(2), 54-64. https://doi.org/10.54536/ajfst.v2i2.2197.
Udoye, J. A., Ozolua, R. I., & Nwokike, J. (2018). Assessment of the knowledge, attitude and practice of pharmacovigilance by pharmacists in two states in southeastern Nigeria. Tropical Journal of Pharmaceutical Research, 17(5), 937-945. https://doi.org/10.4314/tjpr.v17i5.25.
Virstyuk, N. G., Ikwuka, A. O., Haman, I. O., & Adebomi, M. S. (2016). Diabetes mellitus type 2, arterial hypertension and dyslipidemia. Materials of 2nd International Scientific and Practical Conference “Therapeutic readings: modern aspects of diagnosis and treatment of diseases of internal organs”, p. 46-47.
Virstyuk, N. G., & Ikwuka, A. O. (2017a). Diagnostic and prognostic markers of the diabetes mellitus type 2 course in connection with essential arterial hypertension taking into account the kidney function. Precarpathian Journal Pulse, 8(44), 53-62.
Virstyuk, N. H., Ikwuka, A. O., Losyuk, L. V., Kobrynska, O. Ya., & Markiv, H. D. (2017b). Dapagliflozin utility in patients with diabetes mellitus type 2 and essential hypertensive disease. Actual Problems of Modern Medicine, 4(60)1, 76-79. Available online: http://www.umsa.edu.ua/journal2stat4_2017_eng.html
Virstyuk, N. G., & Ikwuka, A. O. (2018a). Features of asymptomatic hyperuricemia in patients with diabetes mellitus type 2 and concomitant essential arterial hypertension. Clinical and Experimental Pathology, 1(63), 22-26. https://doi.org/10.24061/1727-4338.XVII.1.63.2018.5.
Virstyuk, N. G., Ikwuka, A. O., & Didushko, O. M. (2018b). Effect of dapagliflozin on the level of uric acid during asymptomatic hyperuricemia in patients with diabetes mellitus type 2 and concomitant arterial hypertension. Art of Medicine, 1(5), 21-26. Available online: https://art-of-medicine.ifnmu.edu.ua/index.php/aom/article/view/179/150
Virstyuk, N. H., & Ikwuka, A. O. (2018c). Dapagliflozin influence on the clinical course of diabetes mellitus type 2 and essential hypertension in patients. Recent Advances in Environmental Science from the Euro-Mediterranean and Surrounding Regions, p. 2007-2008. https://doi.org/10.1007/978-3-319-70548-4_582.
Virstyuk, N. G., & Ikwuka, A. O. (2019). Nephropathic characteristics in patients with diabetes mellitus type 2 and essential hypertensive disease. Art of Medicine, 1(5), 44-47. https://doi.org/10.21802/artm.2019.1.9.44.
Virstyuk, N. G., & Ikwuka, A. O. (2021a). Asymptomatic hyperuricemia and functional state of the kidneys in patients with essential arterial hypertension and concomitant diabetes mellitus type 2. European Journal of Clinical Medicine, 2(3), 100-104. https://doi.org/10.24018/clinicmed.2021.2.3.65.
Virstyuk, N. H., Ikwuka, A. O., Luchko, O. R., & Kocherzhat, O. I. (2021b). Peculiarities of renal insufficiency in patients with diabetes mellitus type 2 and arterial hypertension. Materials of scientific-practical conference with international participation “Achievements and prospects of experimental and clinical endocrinology” Twentieth Danilevsky readings, p. 86-87.
World Health Organization (WHO). (2019). Medication Safety in Polypharmacy. (WHO/UHC/SDS/2019.11). Available online: https://www.who.int/docs/default-source/patient-safety/who-uhc-sds-2019-11-eng.pdf
Yadesa, T. M., Kitutu, F. E., Deyno, S., Ogwang, P. E., Tamukong, R., & Alele, P. E. (2021). Prevalence, characteristics and predicting risk factors of adverse drug reactions among hospitalized older adults: A systematic review and meta-analysis. SAGE Open Medicine, 9, 20503121211039099. https://doi.org/10.1177/20503121211039099.
Zazzara, M. B., Palmer, K., Vetrano, D. L., Carfì, A., & Graziano, O. (2021). Adverse drug reactions in older adults: a narrative review of the literature. European Geriatric Medicine, 12, 463-473. https://doi.org/10.1007/s41999-021-00481-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Uyiose Fortress Ufuah, Aloysius Obinna Ikwuka, Angus Nnamdi Oli, Brian Ogbonna
This work is licensed under a Creative Commons Attribution 4.0 International License.
